Literature DB >> 25278146

Patterns and correlates of non-fatal heroin overdose at 11-year follow-up: findings from the Australian Treatment Outcome Study.

Shane Darke1, Christina Marel2, Katherine L Mills2, Joanne Ross2, Timothy Slade2, Lucy Burns3, Maree Teesson2.   

Abstract

BACKGROUND: Overdose is a major cause of morbidity and mortality amongst opioid users. This paper reported recent non-fatal overdose amongst the Australian Treatment Outcome Study (ATOS) cohort at 11-year follow-up, and characteristics that predict recent overdose.
METHODS: Longitudinal cohort, with 431 (70.1%) of the original 615 participants interviewed. Participants were administered the ATOS structured interview, addressing demographics, treatment history, drug use, heroin overdose, criminality, health and psychopathology.
FINDINGS: Mean time since heroin initiation was 20.4 years. By 11-year follow-up, the proportion who had overdosed was 67.5%, and 24.4% had experienced five or more overdoses. In the 12 months preceding 11-year follow-up, 4.9% had overdosed (11.8% of those who had used heroin in that period). Of the 21 participants who had recently overdosed, 20 (95.2%) had overdosed previously, and 19 (90.5%) were not enrolled in a treatment programme at the time. Those who had recently overdosed reported higher levels of use of opiates other than heroin (57.1% vs 24.9%), benzodiazepines (61.9% vs 30.5%,), methamphetamine (38.1% vs 16.8%) and cocaine (19.0% vs 3.7%). They also had exhibited higher levels of heroin use and other drug use at baseline, 12 and 24 month follow-ups.
CONCLUSIONS: While the prevalence had declined, overdoses still occurred. A history of overdose and polydrug use patterns continued to provide strong markers for those at continued risk.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cohort; Correlates; Heroin; Longitudinal; Overdose

Mesh:

Substances:

Year:  2014        PMID: 25278146     DOI: 10.1016/j.drugalcdep.2014.09.001

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  8 in total

1.  Geospatial Analysis of Drug Poisoning Deaths Involving Heroin in the USA, 2000-2014.

Authors:  Kathleen Stewart; Yanjia Cao; Margaret H Hsu; Eleanor Artigiani; Eric Wish
Journal:  J Urban Health       Date:  2017-08       Impact factor: 3.671

2.  Risk Factors for Overdose in Treatment-Seeking Youth With Substance Use Disorders.

Authors:  Amy M Yule; Nicholas W Carrellas; Maura Fitzgerald; James W McKowen; Jessica E Nargiso; Brandon G Bergman; John F Kelly; Timothy E Wilens
Journal:  J Clin Psychiatry       Date:  2018 May/Jun       Impact factor: 4.384

3.  Characterising the increasing prevalence of crystal methamphetamine use in Vancouver, Canada, from 2006-2017: A gender-based analysis.

Authors:  Paxton Bach; Kanna Hayashi; M-J Milloy; Ekaterina Nosova; Thomas Kerr; Evan Wood; Nadia Fairbairn
Journal:  Drug Alcohol Rev       Date:  2020-07-14

4.  Concurrent Use of Benzodiazepine by Heroin Users-What Are the Prevalence and the Risks Associated with This Pattern of Use?

Authors:  T Yamamoto; P I Dargan; A Dines; C Yates; F Heyerdahl; K E Hovda; I Giraudon; R Sedefov; D M Wood
Journal:  J Med Toxicol       Date:  2018-07-31

5.  The CHANGE Study: Methods and Sample Description for a Cross-Sectional Study of Heroin Cessation in New York City.

Authors:  Danielle C Ompad; Ebele O Benjamin; Linda Weiss; Joseph J Palamar; Sandro Galea; Jiayu Wang; David Vlahov
Journal:  J Urban Health       Date:  2015-10       Impact factor: 3.671

6.  Evaluation and optimization of take-home naloxone in an academic medical center.

Authors:  Jordan Cooler; Clint A Ross; Sophie Robert; Lauren Linder; Ann Marie Ruhe; Achsah Philip
Journal:  Ment Health Clin       Date:  2019-03-01

Review 7.  Polysubstance use in the U.S. opioid crisis.

Authors:  Wilson M Compton; Rita J Valentino; Robert L DuPont
Journal:  Mol Psychiatry       Date:  2020-11-13       Impact factor: 15.992

8.  Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia.

Authors:  Briony Larance; Louisa Degenhardt; Jason Grebely; Suzanne Nielsen; Raimondo Bruno; Paul Dietze; Kari Lancaster; Sarah Larney; Thomas Santo; Marian Shanahan; Sonja Memedovic; Robert Ali; Michael Farrell
Journal:  Addiction       Date:  2020-02-05       Impact factor: 6.526

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.